Table 1.
Clinical and laboratory data before and after tocilizumab injection.
Days | D1 | D4 | D9 | D10 | D12 | D14 | D16 |
---|---|---|---|---|---|---|---|
Clinically | Fever | Fever | Fever+∗ | Fever+∗ | ∗∗ | ∗∗∗ | ∗∗∗ |
WBC Lymphocytes |
12,700 2.5% |
9600 1.9% |
3500 0.7% |
5.2 1.6% |
5.8 2.1% |
10.4 2.2% |
|
CRP/procal | 126/1.3 | 155/1.54 | 176/84.2 | 45/36 | 7.3/3.9 | <2/0.81 | |
Ferritin D-dimer |
1420 0.7 |
6910 2.2 |
4633 1.2 |
3900 1.0 |
2105 0.8 |
1700 0.9 |
|
eGFR | 21 | 24 | 24 | 31 | 38 | 36 | |
Rx | Tocilizumab | ||||||
HR-CT | Done | Done | Done |
∗Severe diarrhea, worsening of cough, tachypnea, and O2 desaturation. ∗∗No fever, no diarrhea, and cough less. ∗∗∗Asymptomatic.